纳米材料在诊断血栓病中的应用
摘要
目前血栓病发病率高，其对人类健康危害不亚于肿瘤等恶性疾病。但血栓形成至血管栓塞是一个较长期的慢性过程，待患者出现临床症状就诊时，往往已发生不可逆转的脏器损害。因此，提高血栓病的诊断技术、尽早发现和干预血栓形成是降低血栓病危害的有效策略。
出处
《诊断学理论与实践》
2008年第5期481-482,共2页
Journal of Diagnostics Concepts & Practice
参考文献13
-
1[1]Lanza GM,Wallace KD,Scott MJ,et al.A novel sitetargeted ultrasonic contrast agent with broad biomedical application[J].Circulation,1996,94(12):3334-3340.
-
2[2]Hall CS,Marsh JN,Scott M J,et al.Time evolution of enhanced ultrasonic reflection using a fibrin-targeted nanoparticulate contrast agent[J].J Acoust Soc Am,2000,108(6):3049-3057.
-
3[3]Marsh JN,Hall CS,Scott MJ,et al.Improvements in the ultrasonic contrast of targeted perfluoroearbon nano-particles using an acoustic transmission line model[J].IEEE Trans Ultrason Ferroelectr Freq Control,2002,49(1):29-38.
-
4[4]Kaufmann BA,Lindner JR.Molecular imaging with targeted contrast ultrasound[J].Curr Opin Biotechnol,2007,18(1):11-16.
-
5[5]Behm CZ,Lindner JR.Cellular and molecular imaging with targeted contrast ultrasound[J].Ultrasound Q,2006,22(1):67-72.
-
6[6]Hamilton A,Huang SL,Warnick D,et al.Left ventriculax thrombus enhancement after intravenous injection of echogenic immunoliposomes:studies in a new experimental model[J].Circulation,2002,105(23):2772-2778.
-
7[7]Lanza GM,Abendschein DR,Hall CS,et al.In vivo molecular imaging of stretch-induced tissue factor in carotid arteries with ligand-targeted nanoparticles[J].J Am Soc Echocardiogr,2000,13(6):608-614.
-
8[8]Wickline SA,Neubauer AM,Winter PM,et al.Molecular imaging and therapy of atherosclerosis with targeted nanoparticles[J].J Magn Reson Imaging,2007,25(4):667-680.
-
9[9]Caruthers SD,Neubauer AM,Hockett FD,et al.In vitro demonstration using 19F magnetic resonance to augment molecular imaging with paramagnetic perfluorocarbon nanoparticles at 1.5 Tesla[J].Invest Radiol,2006,41(3):305-312.
-
10[10]Winter PM,Caruthers SD,Yu X,et al.Improved molecular imaging contrast agent for detection of human thrombus[J].Magn Reson Med,2003,50(2):411-416.
-
1刘岩峥,田文斌.奥沙利铂的应用研究[J].甘肃医药,2009,28(6):418-419. 被引量：6
-
2莫西沙星更适合治疗CAP[J].医药化工,2005(8):46-46.
-
3赵嫣,任武贤.星点设计效应面法优化多西他赛亚微乳处方工艺[J].中国药物与临床,2017,17(3):364-367. 被引量：1
-
4谢龙,张丽莹.几种铂类抗肿瘤药物的临床应用进展[J].江苏药学与临床研究,2004,12(5):17-19. 被引量：3
-
5陈杰雄,邓小如,吴水新.龙岩市2005—2010年细菌性痢疾流行病学分析[J].海峡预防医学杂志,2013,19(2):34-35. 被引量：2
-
6岑镇波,杨震坤.雷帕霉素洗脱支架治疗冠脉左前降支近中段病变的临床疗效评价[J].心脑血管病防治,2010,10(2):116-118. 被引量：2
-
7曹振环,陈新月.慢性乙型肝炎联合抗病毒治疗研究进展[J].中国病原生物学杂志,2009,4(11):865-867. 被引量：2
-
8赵科伕,胡明霞.2004-2009年合肥市细菌性痢疾流行病学特征分析[J].中华疾病控制杂志,2011,15(6):494-496. 被引量：13
-
9陈新月,吴亚松.慢性乙型肝炎的联合抗病毒治疗[J].医学与哲学（B）,2008,29(7):13-16. 被引量：4
-
10刘珠英,李艳芳.用药差错的原因与其防范的有效策略[J].临床医学工程,2012,19(10):1834-1836. 被引量：1
